VCAM1 and atherosclerosis: Apart from VCAM-1, another biomarker of atherosclerosis to be targeted by various diagnostic scFv is electronegative LDL (−), a physiologically modified LDL that exerts atherogenic effects in macrophages by promoting differentiation and inflammation (101).